Metal binding by pharmaceuticals. Part 4. A comparative investigation of the interaction of metal ions with hydralazine, prizidilol and related compounds

[1]  D. Williams,et al.  Metal binding by pharmaceuticals. Part 3. Copper (II) and zinc (II) interactions with isoniazid , 2005, Agents and Actions.

[2]  M. Castellano,et al.  Effects of prizidilol (SKF 92657) on blood pressure, haemodynamics, sympathetic nervous system activity and plasma volume in essential hypertension. , 1981, Clinical science.

[3]  R. Eden,et al.  Hemodynamic Profile of a New Antihypertensive Agent D,L‐3‐[2‐(3‐t‐Butylamino‐2‐hydroxy‐propoxy)phenyl]‐6‐hydrazinopyridazine (SK&F 92657) , 1981, Journal of cardiovascular pharmacology.

[4]  R. Eden,et al.  Studies on the Autonomic Nervous System with SK&F 92657, a New Antihypertensive Agent Causing Direct Arterial Vasodilatation and β‐Adrenoceptor Blockade , 1981, Journal of cardiovascular pharmacology.

[5]  B. Karlberg,et al.  Prizidilol (SKF 92 657) in primary hypertension , 1981 .

[6]  J. Collier,et al.  Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man. , 1980, British journal of clinical pharmacology.

[7]  M. Boyce,et al.  Assessment in man of SK & F 92657, a novel compound with vasodilator and beta-adrenoceptor blocking activity [proceedings]. , 1980, British journal of clinical pharmacology.

[8]  A. Zanchetti,et al.  Dose-response curve and time course of the antihypertensive effect of SKF 92 657, a beta-receptor-blocking and vasodilating compound. , 1980, Clinical science.

[9]  E. M. Taylor,et al.  SK&F 92657, a novel antihypertensive acting by precapillary vasodilatation and beta-adrenoreceptor blockade. , 1979, Clinical science.

[10]  N. Blumenkrantz,et al.  Effect of hydralazine and dihydralazine on connective tissue and binding to serum protein. , 1979, Scandinavian journal of rheumatology.

[11]  David R. Williams,et al.  An Introduction to bio-inorganic chemistry , 1976 .

[12]  P. Wester.  The urinary excretion of trace elements before and during treatment with hydralazine. , 2009, Acta medica Scandinavica.

[13]  David R. Williams,et al.  Thermodynamic considerations in co-ordination. Part XX. A computerised approach as an alternative to graphical normalised curve fitting as a means of detecting oligonuclear complexes in metal ion–ligand solutions and its application to the zinc(II)–, lead (II)–, and proton–glycine peptide systems , 1975 .

[14]  P. Gans,et al.  Miniquad-A general computer programme for the computation of formation constants from potentiometric data. , 1974, Talanta.

[15]  David R. Williams.  Thermodynamic considerations in co-ordination. Part XIII. Formation constants for the glutaminate– and serinate–proton, –manganese(II), –iron(II), –cobalt(II), –nickel(II), –copper(II), and –zinc(II) systems , 1973 .

[16]  I. Sayce.  Computer calculation of equilibrium constants of species present in mixtures of metal ions and complexing agents. , 1968, Talanta.

[17]  D. D. Perrin,et al.  Computer calculation of equilibrium concentrations in mixtures of metal ions and complexing species. , 1967, Talanta.

[18]  S. Fallab.  Reaktivität von Koordinationsverbindungen VIII. Zur Bildung von Eisen(II)-Chelaten des Phtalazyl-(1)-hydrazyl-Radikals , 1962 .

[19]  S. Fallab,et al.  Reaktivität von Koordinationsverbindungen III. Über Reaktionen der Eisenkomplexe von 1‐Hydrazinophtalazin , 1960 .

[20]  H. Erlenmeyer,et al.  Metallionen‐Gleichgewichte und biologische Aktivität , 1957 .

[21]  Perry Hm,et al.  Studies on the control of hypertension by hyphex. III. Pharmacological and chemical observations on 1-hydrazinophthalazine. , 1954 .